Healthcare Costs Among Patients With CML Receiving Dasatinib or Nilotinib in a Commercial and Medicare Population
PulseAugur coverage of Healthcare Costs Among Patients With CML Receiving Dasatinib or Nilotinib in a Commercial and Medicare Population — every cluster mentioning Healthcare Costs Among Patients With CML Receiving Dasatinib or Nilotinib in a Commercial and Medicare Population across labs, papers, and developer communities, ranked by signal.
1 day(s) with sentiment data
-
Healthcare Costs Rise Due to Pricing Opacity and Provider Consolidation
Healthcare costs continue to escalate due to factors such as opaque hospital pricing, limited transparency in the system, and increasing consolidation among healthcare providers. These issues make it difficult for consu…
-
AI data centers' pollution poses growing public health threat · 3 sources tracked
The burgeoning AI industry's demand for data centers is leading to significant air pollution, according to a report from former EPA officials. These data centers, often powered by natural gas plants, are projected to in…